Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Invo Bioscience Inc (NQ: INVO ) 0.7230 UNCHANGED Streaming Delayed Price Updated: 1:57 PM EDT, Jul 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Invo Bioscience Inc Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK April 19, 2024 Via AB Newswire INVO Bioscience Inc. (NASDAQ: INVO) is One of Wednesday Morning’s Most Active Stocks April 17, 2024 Via Investor Brand Network NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON) January 23, 2024 From NAYA Biosciences Via GlobeNewswire INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors January 17, 2024 From NAYA Biosciences Via GlobeNewswire INVO Bioscience Inc. (NASDAQ: INVO) Leading the Way in Tuesday Trading Based on Percentage Gain November 14, 2023 Via Investor Brand Network BestGrowthStocks.Com Issues Comprehensive Analysis Regarding INVO Biosciences Merger November 13, 2023 Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a... Via TheNewswire.com INVO BIOSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of INVO Bioscience, Inc. - INVO October 24, 2023 From Kahn Swick & Foti, LLC Via Business Wire INVO Bioscience Inc. (NASDAQ: INVO) is One of Monday Morning’s Most Active Stocks October 23, 2023 Via Investor Brand Network BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EngageSmart, Inc. (NYSE – ESMT), Hess Corporation (NYSE – HES), Textainer Group Holdings Limited (NYSE – TGH), INVO Bioscience, Inc. (Nasdaq – INVO) October 23, 2023 From Brodsky & Smith LLC Via GlobeNewswire Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments October 24, 2023 EQNX::TICKER_START (NASDAQ:TCBP),(NYSE:CVM),(NASDAQ:INVO),(NASDAQ:SNY),(NYSE:PFE) EQNX::TICKER_END Via FinancialNewsMedia Exposures Product Safety INVO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of INVO Bioscience, Inc. Is Fair to Shareholders October 23, 2023 From Halper Sadeh LLC Via Business Wire INVO Bioscience Eyes +20 U.S. Cities To Expand Rollout Of Advanced Infertility Treatment 'INVO Centers' February 09, 2022 SAN FRANCISCO, CA / ACCESSWIRE / February 9, 2022 / Today, the global fertility market is a multi-billion industry, yet remains severely underserved, with estimates suggesting more than 90% of couples... From INVO Bioscience, Inc. Via AccessWire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.